Here we have corroborated that GPER-1 is overexpressed in breast cancer cells exposed for 7 days to 1,000 nM tamoxifen (Figure 1A), a concentration similar to that found in breast tissue of patients treated with this drug (24). Here, GPER1 is linked to breast cancer.